KYG0367B1059

Anbio Biotechnology to Showcase Global Diagnostic Innovations at Three Major May ExhibitionsAnbio Biotechnology to Showcase Global Diagnostic Innovations at Three Major May Exhibitions

Anbio Biotechnology to Showcase Global Diagnostic Innovations at Three Major May Exhibitions

BRUSSELS, May 15, 2025 (GLOBE NEWSWIRE) -- Anbio Biotechnology, a global leader in in-vitro diagnostic (IVD) technologies, is pleased to…

2 weeks ago
Anbio Biotechnology AnnouncesClosing of Initial Public OfferingAnbio Biotechnology AnnouncesClosing of Initial Public Offering

Anbio Biotechnology AnnouncesClosing of Initial Public Offering

Frankfurt am Main, Germany, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Anbio Biotechnology (the “Company” or “Anbio”), a global diagnostic company…

3 months ago

Anbio Biotechnology Announces Pricing of Initial Public Offering

Frankfurt am Main, Germany, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Anbio Biotechnology (the “Company” or “Anbio”), a global diagnostic company…

3 months ago